Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
作者信息
Jakubikova Michala, Tyblova Michaela, Tesar Adam, Magda Horakova, Daniela Vlazna, Irena Rysankova, Iveta Novakova, Kristyna Doleckova, Pavel Dusek, Jiri Pitha, Stanislav Vohanka, Josef Bednarik
机构信息
Department of Neurology and Center for Clinical Neuroscience, First Faculty of Medicine and General University Hospital in Prague, Charles University in Prague, Prague, Czech Republic.
Institute of Biophysics and Informatics of the First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
出版信息
Eur J Neurol. 2022 Jan;29(1):e7-e8. doi: 10.1111/ene.15158. Epub 2021 Nov 9.
Abstract
摘要
相似文献
1
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.重症肌无力患者感染新型冠状病毒肺炎（COVID-19）严重病程的预测因素及其对肌无力结局状态和生存的总体影响。
Eur J Neurol. 2022 Jan;29(1):e7-e8. doi: 10.1111/ene.15158. Epub 2021 Nov 9.
2
Comment on "Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic status and survival" by Jakubíková et al.对雅库比科娃等人所著的《重症肌无力患者感染新型冠状病毒肺炎严重病程的预测因素及其对肌无力状态和生存的总体影响》的评论
Eur J Neurol. 2022 Jan;29(1):e5-e6. doi: 10.1111/ene.15131. Epub 2021 Oct 12.
3
Comment on COVID-19 in patients with myasthenia gravis.重症肌无力患者的新型冠状病毒肺炎评论
Muscle Nerve. 2020 Dec;62(6):E85-E86. doi: 10.1002/mus.27063. Epub 2020 Sep 27.
4
Letter response to "The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis".对《重症肌无力和重症肌无力危象中新型冠状病毒感染的双面性》的信件回复
Neurol Sci. 2022 Oct;43(10):5805-5806. doi: 10.1007/s10072-022-06318-y. Epub 2022 Aug 8.
5
Reply to Letter response to "The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis".对“重症肌无力和重症肌无力危象中新型冠状病毒感染的双面性”信件回复的回应
Neurol Sci. 2022 Dec;43(12):6665-6666. doi: 10.1007/s10072-022-06343-x. Epub 2022 Sep 7.
6
The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis.重症肌无力和肌无力危象中新冠病毒感染的双面性
Neurol Sci. 2022 Oct;43(10):5803-5804. doi: 10.1007/s10072-022-06206-5. Epub 2022 Jun 27.
7
Myasthenic crisis in COVID-19.新冠病毒相关性肌无力危象。
J Neurol Sci. 2020 Jul 15;414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6.
8
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.预测重症 COVID-19 感染的因素在重症肌无力患者中对肌无力结局状态和生存有整体影响。
Eur J Neurol. 2021 Oct;28(10):3418-3425. doi: 10.1111/ene.14951. Epub 2021 Jun 25.
9
Does the virus or the doctor promote myasthenic crises in COVID-19 patients with myasthenia?在患有重症肌无力的新冠肺炎患者中，是病毒还是医生引发了重症肌无力危象？
J Clin Anesth. 2021 Jun;70:110166. doi: 10.1016/j.jclinane.2021.110166. Epub 2021 Jan 18.
10
Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19.补体抑制作用启动了 COVID-19 所致严重肌无力危象的恢复。
J Neurol. 2021 Sep;268(9):3125-3128. doi: 10.1007/s00415-021-10428-6. Epub 2021 Feb 4.
引用本文的文献
1
The clinical risk and post-COVID-19 sequelae in patients with myasthenia gravis: a retrospective observational study.重症肌无力患者的临床风险及新冠病毒感染后后遗症：一项回顾性观察研究
Front Neurol. 2025 Apr 2;16:1513649. doi: 10.3389/fneur.2025.1513649. eCollection 2025.
2
Impact of SARS-CoV-2 infection on patients with myasthenia gravis: a retrospective study in a Chinese population.新型冠状病毒2019感染对重症肌无力患者的影响：一项中国人群的回顾性研究
Front Neurol. 2024 Dec 11;15:1482932. doi: 10.3389/fneur.2024.1482932. eCollection 2024.
3
Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis.重症肌无力与2019冠状病毒病：一项系统评价与荟萃分析
Basic Clin Neurosci. 2024 Mar-Apr;15(2):175-184. doi: 10.32598/bcn.2023.4360.5. Epub 2024 Mar 1.
4
A decentralized, prospective, observational study to collect real-world data from patients with myasthenia gravis using smartphones.一项使用智能手机从重症肌无力患者中收集真实世界数据的去中心化、前瞻性观察性研究。
Front Neurol. 2023 Aug 1;14:1144183. doi: 10.3389/fneur.2023.1144183. eCollection 2023.
5
COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis.视神经脊髓炎谱系疾病（NMOSD）患者的 COVID-19 易感性和结局：系统评价和荟萃分析。
Mult Scler Relat Disord. 2022 Jan;57:103359. doi: 10.1016/j.msard.2021.103359. Epub 2021 Nov 1.
本文引用的文献
1
Comment on "Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic status and survival" by Jakubíková et al.对雅库比科娃等人所著的《重症肌无力患者感染新型冠状病毒肺炎严重病程的预测因素及其对肌无力状态和生存的总体影响》的评论
Eur J Neurol. 2022 Jan;29(1):e5-e6. doi: 10.1111/ene.15131. Epub 2021 Oct 12.
2
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.多发性硬化症、视神经脊髓炎谱系疾病和 COVID-19：捷克的大流行之年。
Mult Scler Relat Disord. 2021 Sep;54:103104. doi: 10.1016/j.msard.2021.103104. Epub 2021 Jun 24.
3
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.预测重症 COVID-19 感染的因素在重症肌无力患者中对肌无力结局状态和生存有整体影响。
Eur J Neurol. 2021 Oct;28(10):3418-3425. doi: 10.1111/ene.14951. Epub 2021 Jun 25.
4
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
5
COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?COVID-19 相关的急性呼吸窘迫综合征：是否需要采取不同的治疗方法？
Lancet Respir Med. 2020 Aug;8(8):816-821. doi: 10.1016/S2213-2600(20)30304-0. Epub 2020 Jul 6.
6
Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study.新型冠状病毒肺炎机械通气患者的呼吸病理生理学：一项队列研究
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560-1564. doi: 10.1164/rccm.202004-1163LE.
Zotero 插件